- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02167542
Positive Pressure During Bronchoscopy
Positive Pressure During Bronchoscopy: Noninvasive Positive Pressure Ventilation vs Continuous Positive Airway Pressure Valve
It has been demonstrated the application of noninvasive positive pressure ventilation (NPPV) to assist spontaneous breathing through a face mask during fiberoptic bronchoscopy (FOB) with bronchoalveolar lavage (BAL) in severely hypoxemic, nonintubated patients. With NPPV, FOB was well-tolerated, significantly improved the PaO2/FiO2 ratio, and successfully avoided the need for endotracheal intubation. Two randomized studies have provided supporting evidence that the application of NPPV or CPAP via a face mask was superior to oxygen supplementation alone during FOB.
For this reason patients who require FOB and are hypoxemic and/or mild hypercapnic (TcCO2 < 60mmHg) will be compared in a randomized study by comparing NPPV vs CPAP Boussignac (Vygon) delivered through a face mask.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Since its introduction in the late 1960s, fiberoptic bronchoscopy (FOB) has been increasingly used for diagnostic and therapeutic purposes. Because arterial oxygen tension (PaO2) usually decreases by 10 to 20 mm Hg after uncomplicated bronchoscopy, severe hypoxemia in nonintubated patients is an accepted contraindication to bronchoscopy. The American Thoracic Society recommends avoiding bronchoalveolar lavage (BAL) in spontaneously breathing patients with hypercapnia or hypoxemia that cannot be corrected to at least a PaO2 of 75 mm Hg or to oxygen saturation greater than 90% with supplemental oxygen (1). In these high-risk patients, the options are to intubate and to apply mechanical ventilation (MV) to ensure adequate gas exchange during FOB or to avoid FOB and to institute empirical treatment.
This limitation has prompted the development of techniques of respiratory support to make the FOB procedure safer for hypoxemic or critically ill patients, without using invasive ventilation.
It has been demonstrated the application of noninvasive positive pressure ventilation (NPPV) to assist spontaneous breathing through a face mask during FOB with BAL in severely hypoxemic, nonintubated patients (2). FOB was well-tolerated, significantly improved the PaO2/FiO2 ratio, and successfully avoided the need for endotracheal intubation. Two randomized studies have provided supporting evidence that the application of NPPV or CPAP via a face mask was superior to oxygen supplementation alone during FOB (3,4).
For this reason patients who require FOB and are hypoxemic and/or mild hypercapnic (TcCO2 < 60mmHg) will be compared in a randomized study by comparing NPPV vs CPAP Boussignac (Vygon) delivered through a face mask.
Methods Adult patients will be recuited in Bronchology Department and Intensive Care Units of the Hospital S. João, EPE. Only when inclusion criteria and a written informed consent of participation have been obtained from the patient, they will enter this study.
Before undergoing bronchoscopy all patients will be evaluate by SpO2, TCCO2, arterial blood pressure (ABP), heart rate (HR), respiratory rate (RR) and ECG. Patients with SpO2<92%, oxygen supplementation will be provided to achieve SpO2>92%. At this stage all patients will be randomly assigned to receive NPPV or CPAP Boussignac through a face mask during bronchoscopy. During the procedure, patients will be continuous monitored with ECG, ABP, HR, RR, SpO2 and TCCO2. These clinical parameters will be recorded at the following times: 1 - at evaluation; 2 - before the beginning of FOB; 3 - during FOB; 4 - at the end of FOB; 5 - 5, 15, 30, 60 min after FOB.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Porto, Portugal, 4200-319
- Broncology Unit, Pulmonology Department, University Hospital São João
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- need for FOB;
- hypoxemia, defined by pulse oximetry (SpO2) >92% under oxygen supplementation;
- mild hypercapnia, defined by transcutaneous CO2 (PaCO2) <60mmHg;
- already under domiciliary NPPV.
Exclusion Criteria:
- emergent intubation;
- recent (less than 1 wk) acute myocardial infarction;
- ph bellow 7.30;
- PaCo2 > 60mmHg;
- systolic blood pressure < 80mmHg;
- encephalopathy or coma.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: NPPV group
Patients assigned to noninvasive positive pressure ventilation (NPPV) are connected to the ventilator through a face mask (VBM Endoscopy Mask) that is secured to the patient's face by the investigator.
|
Patients assigned to NPPV were connected to the ventilator through a face mask (VBM Endoscopy Mask) that was secured to the patient's face by the investigator.
Only one type of mechanical ventilator will be used (Vision, Philips Respironics).
Ventilator parameters and supplemental oxygen will be titrated by the investigator to achieve SpO2>92%.
Ventilatory support via face mask will be maintained with the same pressures for at least 30min after FOB, and then will be replaced by the FIO2 mask's if needed.
|
Active Comparator: CPAP valve group
Patients assigned to CPAP valve (Boussignac valve, Vygon, Inc) are connected to this device through a standard face mask that is secured to the patient's face with elastic straps.
|
Patients assigned to CPAP Boussignac valve are connected to this device through a face mask that is secured to the patient's face with elastic straps. This kind of CPAP allows the delivery of pressure by constant-flow oxygen insufflation. Four funnel-shaped microchannels are included in the wall of this device and connected to an external opening connected to the oxygen source. These microchannels generate high-velocity microjets, which in turn generate the pressure resulting from the air entrainment mechanism thus created. Oxygen flow will be titrated by the investigator to ensure SpO2>92%. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in arterial parcial oxygen pressure / Inspired oxygen fraction ratio (PaO2/FiO2)
Time Frame: Before and 5 min after the exam (FOB)
|
Before and 5 min after the exam (FOB)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Electrocardiogram
Time Frame: up to 60 min after FOB
|
up to 60 min after FOB
|
Heart Rate
Time Frame: up to 60 min after FOB
|
up to 60 min after FOB
|
Respiratory Rate
Time Frame: up to 60 min after FOB
|
up to 60 min after FOB
|
Peripheal oxygen saturation
Time Frame: up to 60 min after FOB
|
up to 60 min after FOB
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Miguel R Gonçalves, Ph.D, Lung Function and Ventilation Unit, Pulmonology Department, University Hospital São João
- Principal Investigator: Tiago F Pinto, MSc, Lung Function and Ventilation Unit, Pulmonology Department, University Hospital São João
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BroncoNIVCPAP
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Respiratory Failure With Hypoxia
-
Columbia UniversityRecruitingAcute Respiratory Failure With HypoxiaUnited States
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Unknown
-
Hospital Clinic of BarcelonaUbikare companyUnknown
-
University Hospital, RouenCompletedAcute Respiratory Failure With Hypoxia
-
Hôpital Louis MourierUnknownHypoxemia | Acute Respiratory Failure With HypoxiaFrance
-
Jesus VillarRecruiting
-
Belfast Health and Social Care TrustQueen's University, Belfast; Northern Ireland Clinical Trials UnitActive, not recruitingAcute Respiratory Failure With HypoxiaUnited Kingdom
-
University of ArizonaEunice Kennedy Shriver National Institute of Child Health and Human Development...TerminatedMalnutrition | Acute Respiratory Failure With HypoxiaUnited States
-
Jens BräunlichRecruitingDiaphragm Issues | Respiratory Failure With Hypoxia | Respiratory Failure With Hypercapnia | Non-invasive Mechanical VentilationGermany
-
Centre Hospitalier Régional d'OrléansCompletedAcute Respiratory Failure With Hypoxia | Oxygen Inhalation Therapy | Prehospital SettingFrance
Clinical Trials on Noninvasive Positive Pressure Ventilation
-
The First Affiliated Hospital of Guangzhou Medical...UnknownCOPD | Hypercapnic Respiratory FailureChina
-
Columbia UniversityTerminatedMotor Neuron Disease | Amyotrophic Lateral SclerosisUnited States
-
The First Affiliated Hospital of Guangzhou Medical...CompletedChronic Obstructive Pulmonary DiseaseChina
-
Groningen Research Institute for Asthma and COPDThe Netherlands Asthma FoundationUnknownPulmonary Disease, Chronic ObstructiveNetherlands
-
Beijing Chao Yang HospitalUnknownAcute Respiratory Distress Syndrome | Acute Lung InjuryChina
-
Beijing Chao Yang HospitalWithdrawnAcute Hypoxemic Respiratory FailureChina
-
University of MichiganCompletedSpontaneous VentilationUnited States
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedAmyotrophic Lateral SclerosisUnited States
-
UPECLIN HC FM Botucatu UnespUnknownExtubation Failure | Acute Respiratory Failure Post ExtubationBrazil